| 1GNG | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | PTR, SO4, TRS | enzyme |
| ||||||||||||
| note | 1GNG is a representative structure | ||||||||||||||
| related structures | by homologous chain: 1I09, 1O9U | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation., Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, Reith AD, Structure (Camb) 2001 Dec;9(12):1143-52. PMID:11738041 | ||||||||||||||
| Data retrieval |
![]() |
| View 1GNG in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |